Cargando…
Biomarkers for Point-of-Care Diagnosis of Sepsis
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. In 2017, almost 50 million cases of sepsis were recorded worldwide and 11 million sepsis-related deaths were reported. Therefore, sepsis is the focus of intense research to better understan...
Autores principales: | Teggert, Andrew, Datta, Harish, Ali, Zulfiqur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143187/ https://www.ncbi.nlm.nih.gov/pubmed/32164268 http://dx.doi.org/10.3390/mi11030286 |
Ejemplares similares
-
Micro- and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care
por: Alba-Patiño, Alejandra, et al.
Publicado: (2022) -
Fabrication Methods for Microfluidic Devices: An Overview
por: Scott, Simon M., et al.
Publicado: (2021) -
COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis
por: Etienne, Ernst Emmanuel, et al.
Publicado: (2021) -
Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics
por: Kiss, Helga, et al.
Publicado: (2023) -
Potential biomarker for diagnosis and therapy of sepsis: Lactylation
por: Sun, ZeXian, et al.
Publicado: (2023)